Guangzhou Wondfo Biotech Co Ltd
SZSE:300482

Watchlist Manager
Guangzhou Wondfo Biotech Co Ltd Logo
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Watchlist
Price: 24.29 CNY -6.22% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Guangzhou Wondfo Biotech Co Ltd?
Write Note

Guangzhou Wondfo Biotech Co Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Guangzhou Wondfo Biotech Co Ltd
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
PP&E Gross
ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
PP&E Gross
ÂĄ464.5m
CAGR 3-Years
43%
CAGR 5-Years
35%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
PP&E Gross
ÂĄ2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
PP&E Gross
ÂĄ9.4B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
PP&E Gross
ÂĄ1.9B
CAGR 3-Years
16%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
PP&E Gross
ÂĄ3.3B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Guangzhou Wondfo Biotech Co Ltd
Glance View

Market Cap
11.5B CNY
Industry
Health Care

Guangzhou Wondfo Biotech Co., Ltd. engages in the manufacture and sale of biochemical reagents, medical products and diagnostic test kits. The company is headquartered in Guangzhou, Guangdong and currently employs 3,411 full-time employees. The company went IPO on 2015-06-30. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The firm's products are used in POCT, clinical test, field test and personal health management, among others.

Intrinsic Value
42.67 CNY
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Guangzhou Wondfo Biotech Co Ltd's PP&E Gross?
PP&E Gross
1.4B CNY

Based on the financial report for Sep 30, 2024, Guangzhou Wondfo Biotech Co Ltd's PP&E Gross amounts to 1.4B CNY.

Back to Top